Mechanisms of action of SGLT2 inhibitors in patients with heart failure with reduced ejection fraction (HFrEF) (ACTRN12621000187842)

DAPA_HF

This trial is Currently recruiting
Registration number ACTRN12621000187842

Program & service

This trial is being run with the Heart & Lung service, and as part of the Cardiology program.

Trial phase

Other

Trial participation type

This trial has been designed for the Clinical Research of a Drug.

Principal investigator

Professor David Kaye

More information

To find out more about this clinical trial, please review full details on the ANZCTR website.

View on ANZCTR

If you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.